tiprankstipranks
Advertisement
Advertisement

FEMY Stock Latest News

Femasys updates corporate presentation on women’s health portfolio
Company AnnouncementsFemasys updates corporate presentation on women’s health portfolio
11d ago
8K
FEMY
Femasys announces CE Mark approval for FemHSG Catheter
PremiumThe Fly
Femasys announces CE Mark approval for FemHSG Catheter
11d ago
FEMY
Femasys Reverse Stock Split May Not Prevent Nasdaq Delisting Risk, Observer Warns
PremiumCompany Announcements
Femasys Reverse Stock Split May Not Prevent Nasdaq Delisting Risk, Observer Warns
15d ago
FEMY
Femasys Shareholders Approve Reverse Split and Financing Plans
PremiumCompany Announcements
Femasys Shareholders Approve Reverse Split and Financing Plans
25d ago
8K
FEMY
Femasys drives growth with Israeli market entry for fertility portfolio
PremiumThe Fly
Femasys drives growth with Israeli market entry for fertility portfolio
1M ago
FEMY
Femasys Names John Canning as New Chief Operating Officer
PremiumCompany AnnouncementsFemasys Names John Canning as New Chief Operating Officer
2M ago
8K
FEMY
Femasys management to meet virtually with Lake Street
Premium
The Fly
Femasys management to meet virtually with Lake Street
2M ago
FEMY
FEMY Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
FEMY Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
FEMY
Femasys Amends Financing Terms and Issues New Warrants
PremiumCompany Announcements
Femasys Amends Financing Terms and Issues New Warrants
2M ago
8K
FEMY
Femasys appoints Kenneth Eichenbaum to its Board of Directors
PremiumThe Fly
Femasys appoints Kenneth Eichenbaum to its Board of Directors
2M ago
FEMY
Femasys advances FemBloc to U.S. approval with initiation of trial enrollment
PremiumThe Fly
Femasys advances FemBloc to U.S. approval with initiation of trial enrollment
3M ago
FEMY
Femasys initiated with a Buy at Lake Street
PremiumThe Fly
Femasys initiated with a Buy at Lake Street
3M ago
FEMY
Femasys’s FemBloc Pivotal Trial Update: What Investors Should Watch in Women’s Health
PremiumCompany AnnouncementsFemasys’s FemBloc Pivotal Trial Update: What Investors Should Watch in Women’s Health
3M ago
FEMY
Femasys FemBloc achieved certification under MDSAP
Premium
The Fly
Femasys FemBloc achieved certification under MDSAP
3M ago
FEMY
Femasys receives AMA CPT Editorial Panel approval for new CPT code
Premium
The Fly
Femasys receives AMA CPT Editorial Panel approval for new CPT code
3M ago
FEMY
Femasys enters distribution partnership with OR Consulting
PremiumThe Fly
Femasys enters distribution partnership with OR Consulting
4M ago
FEMY
Femasys Receives Nasdaq Extension to Regain Listing Compliance
PremiumCompany Announcements
Femasys Receives Nasdaq Extension to Regain Listing Compliance
4M ago
8K
FEMY
Femasys granted 180-day extension by Nasdaq to regain compliance
PremiumThe Fly
Femasys granted 180-day extension by Nasdaq to regain compliance
4M ago
FEMY
Femasys announces partnership with Refuah Health Center
PremiumThe Fly
Femasys announces partnership with Refuah Health Center
4M ago
FEMY
Femasys files to sell 68.42M shares of common stock for holders
PremiumThe FlyFemasys files to sell 68.42M shares of common stock for holders
5M ago
FEMY
Femasys Launches At-the-Market Common Stock Offering
Premium
Company Announcements
Femasys Launches At-the-Market Common Stock Offering
5M ago
8K
FEMY
Femasys Gains FDA Clearance for FemVue Diagnostic Device
Premium
Company Announcements
Femasys Gains FDA Clearance for FemVue Diagnostic Device
5M ago
8K
FEMY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >